Skip to main content

Table 1 The biochemical parameters of CON, STZ-DM, DM-R0.1 and DM-R1 rats

From: Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase

 

CON (n = 11)

STZ-DM (n = 7)

DM-R0.1 (n = 11)

DM-R1 (n = 15)

Body weight (g)

420.77 ± 8.88

280.29 ± 9.41*

330.77 ± 9.45*†

312.81 ± 10.55*†

Plasma glucose (mg/dl)

137.15 ± 10.86

566.33 ± 45.24*

444.17 ± 22.90*†

376.48 ± 35.56*†

Plasma insulin (μg/l)

2.00 ± 0.28

0.11 ± 0.06*

0.78 ± 0.25*†

0.86 ± 0.12*†

Plasma cholesterol (mg/dl)

67.30 ± 9.63

111.13 ± 16.98*

59.51 ± 7.16†

48.05 ± 5.64†

Plasma triglycerides (mg/dl)

88.27 ± 11.41

166.41 ± 35.43*

55.84 ± 7.47*†

63.52 ± 9.20†

Blood urea nitrogen (mg/dl)

16.27 ± 0.94

25.01 ± 3.90*

19.97 ± 1.52*

21.73 ± 1.72*

Plasma creatinine (mg/dl)

0.37 ± 0.04

0.59 ± 0.10*

0.41 ± 0.04†

0.48 ± 0.04

  1. Values were expressed as means ± standard error (n = 7~15 per group). CON: non-diabetic control, STZ-DM: streptozotocin-induced diabetes, DM-R0.1: DM treated with RSV (0.1 mg/kg/day) for 7 days, DM-R1: DM treated with RSV (1 mg/kg/day) for 7 days.
  2. *: P < 0.05 vs. control, †: P < 0.05 vs. STZ-DM, ‡: P < 0.05 vs. DM-R0.1.